Why the study?
Do beta-blockers reduce mortality compared to diuretics in patients with hypertension?
Do beta-blockers reduce mortality compared to diuretics in patients with hypertension?
Answers are grounded in this paper and cite their sources.
This reply clarifies the protocol and mortality findings of the MAPHY study comparing beta-blockers and diuretics in hypertension.
In Reply.— The protocol for the trial of β-blockers vs diuretics in hypertension was defined in 1975. All centers randomized patients either to metoprolol or a diuretic counterpart, with the exception of one center with 46 patients taking propranolol (atenolol was not included as an option in the original study). More than two years after the first patient was randomized, a separate part randomizing patients to atenolol or diuretics was started (Fig 2). Many patients were followed up for only one year in this part, partially explaining a low mortality rate, probably about six deaths per 1000 patient-years in the diuretic-treated group. That tendencies in one or the other direction may occur when mortality rates are low, as in the part comparing atenolol with diuretics, might be expected by chance. This does not change the interpretation of the results of the MAPHY Study since, as pointed out by the chairman
No takes yet. Share an insight, caveat, or question.
John Wikstrand (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: